SCHEMBL10195136

SCHEMBL10195136

CCc1ccc(Oc2ncc(Cl)cc2Cl)cc1C1=C(O)C(C)(C)OC(C)(C)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
APEX1 P27695 1/20 0.43
LIPE Q05469 4/20 0.41
BCHE P06276 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
DRD1 P21728 3/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
IP6K1 Q92551 2/20 0.36
IP6K3 Q96PC2 2/20 0.36
IP6K2 Q9UHH9 2/20 0.36
PPARG P37231 1/20 0.36
SCN9A Q15858 1/20 0.35
RAB9A P51151 1/20 0.33
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16181143 0.91 DRD1 (0.40) MAPK1SMN1; SMN2LMNACYP2C9TSHR
SCHEMBL16180986 0.91 DRD1 (0.40) MAPK1SMN1; SMN2LMNACYP2C9TSHR
SCHEMBL10195276 0.91 MAPK1 (0.37) MAPK1SMN1; SMN2LMNACYP2C9TSHR
SCHEMBL10195148 0.91 PPARG (0.38) MAPK1SMN1; SMN2LMNACYP2C9TSHR
SCHEMBL10195261 0.88 MAPK1 (0.34) MAPK1SMN1; SMN2LMNACYP2C9TSHR
SCHEMBL10195140 0.88 RAB9A (0.49) SMN1; SMN2LMNALIPEPPARGRAB9A
SCHEMBL10195282 0.87 MAPK1 (0.34) MAPK1SMN1; SMN2LMNACYP2C9TSHR
SCHEMBL10195211 0.87 KDM4E (0.30) MAPK1KDM4E
SCHEMBL10195260 0.85 DHFR (0.34) MAPK1TSHRL3MBTL1MAPTTDP1
SCHEMBL10195256 0.85 F2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAPK1 2927/4885SMN1; SMN2 2218/4885LMNA 4151/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAPK1 2263/4885SMN1; SMN2 2952/4885LMNA 4657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.